VERA CASTELLANO: Open Payments
NPI 1831849314 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$289 in 7 payments from 4 companies in 2025. Trend: 2023 $134 · 2024 $317 · 2025 $289
Food & beverage: $289
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 3 | $198 |
| Novo Nordisk Inc | 2 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Amgen Inc. | 1 | $15 |
Products named: CDS broad portfolio offering, LATITUDE Communicator Power Supply, LUX-Dx Insertable Cardiac Monitor, Ozempic, Kerendia, Saxenda, REPATHA.
Industry payments across NV — which companies pay providers there.
